Servier is a privately held international pharmaceutical company headquartered in France with a passion for innovation that has improved patients’ lives around the world. With $4.7 billion in annual sales Servier operates in almost 150 countries worldwide across five therapeutic categories including oncology, cardiovascular, immuno-inflammatory, neuroscience and diabetes.
Servier is founded on the principle of serving and governed by an independent non-profit foundation. With this unique operating model, the company can be deliberate about putting patients ahead of profits. In fact, Servier re-invests 25 percent of revenue into research and development each year.
Servier is committed to therapeutic progress to serve patient needs and strives to provide future generations with a world where quality healthcare is available and accessible to all.
See our community guidelines here: https://www.servier.us/community-guidelines
To report a suspected adverse event with a Servier product, please visit: https://www.servier.us/contact-us
|
|
|
|
|
501-1,000 employees
View all Servier Pharmaceuticals employees
|
|
|
Pharmaceuticals
|
|
|
200 Pier Four Boulevard, Boston, MA 02210, US
|
|
|
2018
|
Chadi Maroun is the CEO of Servier Pharmaceuticals. To contact Chadi Maroun email at [email protected].
The decision makers in Servier Pharmaceuticals are Alaina Pleatman, David K Lee, Justin Cidado, etc. Click to Find Servier Pharmaceuticals decision makers emails.
Find accurate personal emails, work emails and phone numbers for employees
Accelerate prospecting with instant access to 350M professionals from 40M companies with the right contact details.